Kodai Kunisada^1*, Taku Kikuchi, MD^2*, Nobuhiro Tsukada, MD, PhD³, Tomomi Takei, MD^1*, Moe Yogo^1*, Kota Sato^1*, Mizuki Ogura^1*, Yu ABE^1*, Kenshi Suzuki, MD, PhD¹ and Tadao Ishida¹

¹Japanese Red Cross Medical Center, Tokyo, Japan
²Keio University School of Medicine, Tokyo, Japan
³Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan

David B. Sykes, MD, PhD¹, Mohammad Artin Houshmand, Ph.D.^2*, Tysheena P. Charles, PhD^3*, Jens Wrammert, PhD^3* and Wilfried A Schroyens, MD, PhD^4*

¹Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
²Biocytogen, Waltham, MA
³Department of Pediatrics, Emory University, Atlanta, GA
⁴University Hospital Antwerp, Antwerp, Belgium

Majdolen Joleen Istaiti^1*, Katie Thoren, PhD, DABCC FAACC^2*, Shoshana Revel-Vilk, MD, PhD^1,3, Ari Zimran, MD^1,3 and Ola Landgren⁴

¹Gaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel
²Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Faculty of Medicine, Hebrew University, Jerusalem, Israel
⁴Sylvester Comprehensive Cancer Center, Miami, FL

David Dingli, MD, PhD¹, Darlyna Khonkhammy^2*, Caden Gunnarson^2*, Zach Morena^3*, Dan Que^2* and Ali Khammanivong^2*

¹Mayo Clinic, Rochester, MN
²Oncodea Corporation, St Paul, MN
³Oncodea Corporation, St Paul

David Dingli, MD, PhD¹, Darlyna Khonkhammy^2*, Caden Gunnarson^2*, Zach Morena^3*, Dan Que^2* and Ali Khammanivong^2*

¹Mayo Clinic, Rochester, MN
²Oncodea Corporation, St Paul, MN
³Oncodea Corporation, St Paul

Philippe Decruyenaere, MD^1,2,3*, Daniela Drandi^4*, Kimberly Verniers^2,3*, Simone Ragaini^4*, Jasper Anckaert^2,3*, Veronica Peri^4*, Elisa Genuardi^4*, Federica Cavallo^4,5*, Luigi Marcheselli^6*, Irene Dogliotti, MD^5*, Emanuele Cencini, MD^7*, Dario Marino^8*, Angela Ferrari^9*, Simona Tomassetti^10*, Luca Laurenti, MD^11*, Giacomo Loseto^12*, Monia Marchetti, MD, PhD^13*, Annelien Morlion^2,3*, Ramon García-Sanz, MD, PhD¹⁴, Fritz Offner^1*, Benedetto Bruno, MD, PhD^5,15, Marzia Varettoni^16*, Jo Vandesompele^2,3* and Simone Ferrero, MD^4,5

¹Department of Hematology, Ghent University Hospital, Ghent, Belgium
²OncoRNALab, Cancer Research Institute Ghent (CRIG), Ghent, Belgium
³Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
⁴Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, Italy
⁵Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
⁶Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
⁷Division of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
⁸Oncologia 1 - I.R.C.C.S. Istituto Oncologico Veneto, Padova, Padova, Italy
⁹IRCCS - Arcispedale Santa Maria Nuova, Hematology, Reggio Emilia, Reggio Emilia, Italy
¹⁰Ematologia - Ospedale degli Infermi di Rimini, Rimini, Italy
¹¹Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Roma, Università Cattolica del Sacro Cuore, Rome, Italy
¹²IRCCS Istituto Tumori “Giovanni Paolo II”, Hematology Unit, Bari, Bari, Italy
¹³Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Alessandria, Italy
¹⁴Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
¹⁵Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
¹⁶Division of Hematology, Fondazione IRCCS Policlinico S. Matteo University of Pavia, Pavia, Italy

Francesca Cottini, MD¹, Ana Maria Avila Rodriguez, MD², Karen Sweiss, PharmD³, Chukwuemeka Uzoka, MD^4*, Zhengjia Chen, PhD^5*, Weiwei Ma, MS^6*, Elvira Umyarova, MD¹, Anjali Satoskar^7*, Pierre Rodriguez, MD^8* and Matias Sanchez, MD³

¹Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
³Division of Hematology/Oncology, University of Illinois Cancer Center, Chicago, IL
⁴Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
⁵Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL
⁶Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois, Chicago, IL
⁷Ohio State University, Columbus, OH
⁸1950 W.Polk St.Chicago, IL, John Stroger,Jr.Hospital of Cook County, Chicago, IL

Greeshma Gaddipati, MBBS¹, Boniface Mensah, MBChB, MPH^2*, Chiranjeevi Sainatham, MBBS^3*, Greeshma Erasani, MBBS^4*, Mariah Malak Bilalaga, MBBS^2*, Ramya Vasireddy, MBBS^2*, Shree Rath^5*, Joseph Atarere^2*, Sujitha Ketineni, MD⁶ and Mahsa Mohebtash, MD^2*

¹MedStar Union Memorial Hospital, Towson, MD
²MedStar Union Memorial Hospital, Baltimore, MD
³Internal Medicine, Sinai hospital of Baltimore, Baltimore, MD
⁴University of Missouri- Kansas City School of Medicine, Kansas city
⁵All India Institute of Medical Sciences, Bhubaneswar, India
⁶SIU School of medicine, Springfield, IL

Hannah Belcher, BN^1*, James Duffell, MA MBBChir MRCP^1,2*, Laura Williams, BSc, MRes, SBMS, HCPC^3* and Ceri Bygrave, MBBCh MRCP FRCPath^1,4*

¹Department of Haematology, Cardiff & Vale University Health Board, Cardiff, United Kingdom
²Department of Haematology, Swansea Bay University Health Board, Swansea, United Kingdom
³Department of Immunology, Cardiff & Vale Health Board, Cardiff, United Kingdom
⁴Department of Haematology, Cardiff University, Cardiff, United Kingdom

Midori Filiz Nishimura, MD, PhD^1*, Yoshito Nishimura, MD, PhD, MPH², Yuika Iwamoto^3*, Tomoka Haratake^4*, Hideki Ujiie^4*, Asami Nishikori, PhD^1*, Thomas M. Habermann, MD⁵, Angela Dispenzieri, MD⁵ and Yasuharu Sato, PhD^6*

¹Department of Molecular Hematopathology, Okayama University School of Medicine, Okayama, JPN
²Mayo Clinic, Honolulu, HI
³Department of Molecular Hematopathology, Okayama University School of Medicine, Okayama, Japan
⁴Okayama University School of Medicine, Okayama, JPN
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Department of Molecular Hematopathology, Okayama University, Okayama, Japan

Xia Wu, MD^1*, Denis Toskic, BS^2*, Teresa Fogaren, NP^3*, Nancy Coady Lyons, NP^3*, Vasil Mico, MD^4*, Ping Zhou, MD, PhD^5*, Stephanie Scalia^5*, Xun Ma, DDM, PhD^5* and Raymond Comenzo, MD^5,6

¹Department of Internal Medicine, Tufts Medical Center, Boston, MA
²The John Davis Myeloma and Amyloid Program, Tufts Medical Center, Revere, MA
³Division of Hematology-Oncology, Department of Medicine, Tufts Medical Center, Boston, MA
⁴Department of Internal Medicine, Tufts Medical Center, Boston
⁵Tufts Medical Center, Boston, MA
⁶Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA

Katie Y Li^1*, Andrew Staron, MD^1,2, Vaishali Sanchorawala^1,2 and Raphael E. Szalat, MD, PhD^2,3

¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
³Section of Hematology and Medical Oncology, Boston Medical Center, Boston, MA

Pedro G Vianna, MD^1,2, Shahrier Hossain, PharmD^1*, Shannon Miller^1*, Annemarie Rossi^1*, Sarah AM Cuddy, MD^3*, Rodney H Falk, MD^3*, Jacob P. Laubach^1* and Giada Bianchi, MD^1,4

¹Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
²Amyloidosis Program, Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Brookline, MA
³Amyloidosis Program, Cardiovascular Division, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA
⁴Amyloidosis Program, Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Matthew James Rees, MD¹, Eli Muchtar, MD¹, Suheil Albert Atallah-Yunes, MD¹, Surendra Dasari, PhD^2*, Nelson Leung, MD³, Morie A. Gertz, MD¹, Angela Dispenzieri, MD¹, Ellen McPhail, MD⁴, Shaji Kumar, MD¹, Emilie Anderson, M.S.^5*, Christopher Dick, MS^6* and Taxiarchis Kourelis, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Department of Laboratory Medicine, Mayo Clinic, Rochester, MN
⁵Division of Hematology Research, Mayo Clinic, Rochester, MN
⁶Mayo Foundation for Medical Education and Research, Mayo Clinic, Rochester, MN

Cecilie Velsoe Maeng, MD^1*, Sæmundur Rögnvaldsson, MD, PhD^2,3*, Thorir Long, MD, PhD^4,5*, Christian Brieghel, MD, PhD^6*, Carsten Utoft Niemann, MD, PhD^7*, Kirsten Gronbaek, MD, PhD, PR¹, Sigurdur Y Kristinsson⁴ and Sigrun Thorsteinsdottir, MD, PhD^1,4

¹Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
²Faculty of Medicine, University of Iceland, Reykjavík, Iceland
³Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland
⁴Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁵Skåne University Hospital, Lund, Sweden, Skåne, Sweden
⁶Department of Hematology, Copenhagen University Hospital, Rigshospitalet, København Ø, Denmark
⁷Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark

Rajvi Gor, MBBS¹, Jeevan Shivakumar, MD^2*, Pallavi Surana, MD^3*, John X Wei, MD⁴, Irina Murakhovskaya, MD⁴, Mendel Goldfinger^4*, Noah Kornblum, MD⁵, Lauren Shapiro, MD⁵, Aditi Shastri, MD⁴, Ridhi Gupta, MD^6*, David Levitz, MD⁴, Marina Konopleva, MD⁴, Eric J. Feldman, MD^5*, Kira Gritsman, MD, PhD⁵, R. Alejandro Sica, MD⁴, Ioannis Mantzaris, MD⁶, Amit Verma, MD⁴, Dennis L Cooper, MD⁴, Murali Janakiram, MBBS⁷ and Nishi Shah, MBBS, MPH⁴

¹Jacobi Medical Center/ Albert Einstein College of Medicine, Bronx, NY
²Montefiore Medical Center, Bronx, NY
³Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
⁴Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
⁵Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁶Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁷Division of Myeloma, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA

Nadia Toumeh, MD^1*, Matthew James Rees, MD², Morie A. Gertz, MD², Angela Dispenzieri, MD², Binoy Yohannan, MD³, Suheil Albert Atallah-Yunes, MD², Prashant Kapoor, MD⁴, Taxiarchis Kourelis, MD², Nelson Leung, MD⁵, Suzanne R Hayman, MD², Francis Buadi, MD², David Dingli, MD, PhD², Joselle Cook, MBBS², Rahma M Warsame, MD², Moritz Binder, MD², Wilson I. Gonsalves, MD², S. Vincent Rajkumar, MD², Shaji Kumar, MD² and Eli Muchtar, MD²

¹Internal Medicine, Mayo Clinic Rochester, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³U Texas Medical School, Houston, TX
⁴Mayo Clinic, Rochester, MN
⁵Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Sara Oubari, MD.^1*, Maria Papathanasiou^2*, Lars Christian Michel^3*, Tienush Rassaf^4*, Andreas Thimm^4*, Tim Hagenacker^4*, Daniela Ehling^5*, Stefan Wieczorek^5*, Eyad Naser^4*, Ulrich Duehrsen, MD^6*, Hans Christian Reinhardt, MD⁷ and Alexander Carpinteiro^8*

¹Department of hematology and stem cell transplantation, University Hospital Essen, Essen, Germany
²Department of Cardiology and Angiology, University Hospital Frankfurt, Frankfurt, DEU
³University Hospital Essen, Essen, North-Rhine Westphalia, DEU
⁴University Hospital Essen, Essen, DEU
⁵Department of Medical Genetics, MVZ Dr. Eberhard & Partner Dortmund, Dortmund, Germany
⁶Universitaetsklinikum Essen, Klinik Fuer Haematologie, Essen, DEU
⁷Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁸Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, DEU

Patrick Hagen, MD, MPH^1*, Surbhi Sidana, MD², Terri L. Parker, MD³, Brian A. Walker, PhD⁴, Vaishali Sanchorawala⁵, Jeffrey A. Zonder, MD ⁶, Taxiarchis Kourelis, MD⁷, Anita D'Souza, MD^8,9, Heather J. Landau, MD¹⁰, Adam Rosenthal, MS^11*, Antje Hoering, PhD¹², Sikander Ailawadhi¹³ and Robert Z. Orlowski, MD, PhD¹⁴

¹Division of Hematology and Oncology, Loyola University Health System, Maywood, IL
²Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
³Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
⁴Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN
⁵Amyloidosis Center, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁶Karmanos Cancer Institute, Detroit, MI
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁹Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁰Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹SWOG Statistical and Data Management Center, Seattle, WA
¹²Cancer Research And Biostatistics, Seattle, WA
¹³Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
¹⁴Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX